Chalazia Associated with Bortezomib Therapy for Multiple Myeloma

被引：13
|
作者：
Grob, Seanna R. [1 ,3 ]
Jakobiec, Frederick A. [2 ,3 ]
Rashid, Alia [2 ,3 ]
Yoon, Michael K. [1 ,3 ]
机构：
[1] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
[2] Massachusetts Eye & Ear Infirm, David G Cogan Ophthalm Pathol Lab, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA
来源：
OPHTHALMOLOGY | 2014年 / 121卷 / 09期
关键词：
D O I：
10.1016/j.ophtha.2014.04.021
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：1845 / 1847
页数：5
相关论文
共 50 条
  • [21] Bortezomib in multiple myeloma
    Mateos, M. V.
    Miguel, J. F. San
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) : 701 - 715
  • [22] Bortezomib in multiple myeloma
    Cecchi, M
    Caccese, E
    Messori, A
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (12): : 1297 - 1297
  • [23] Bortezomib in multiple myeloma
    不详
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (16) : 2335 - 2335
  • [24] Bortezomib in multiple myeloma
    Terpos, Evangelos
    Roussou, Maria
    Dimopoulos, Meletios-Athanassios
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (05) : 639 - 654
  • [25] Recurrent Chalazia Secondary to Bortezomib
    Hanisah, Fatin F.
    Asnida, Rona N.
    Jemaima, C. H.
    MEDICINE AND HEALTH-KUALA LUMPUR, 2018, 13 (02): : 217 - 222
  • [26] Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy
    J R Berenson
    J D Hilger
    O Yellin
    R Dichmann
    D Patel-Donnelly
    R V Boccia
    A Bessudo
    L Stampleman
    D Gravenor
    S Eshaghian
    Y Nassir
    R A Swift
    R A Vescio
    Leukemia, 2014, 28 : 1529 - 1536
  • [27] Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy
    Berenson, J. R.
    Hilger, J. D.
    Yellin, O.
    Dichmann, R.
    Patel-Donnelly, D.
    Boccia, R. V.
    Bessudo, A.
    Stampleman, L.
    Gravenor, D.
    Eshaghian, S.
    Nassir, Y.
    Swift, R. A.
    Vescio, R. A.
    LEUKEMIA, 2014, 28 (07) : 1529 - 1536
  • [28] A new generation therapy of multiple myeloma by proteaosome inhibitor bortezomib
    Terui, Yasuhito
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 39P - 39P
  • [29] Bortezomib and lenalidomide as front-line therapy for multiple myeloma
    Zou, Yandun
    Lin, Mingzhen
    Sheng, Zhixin
    Niu, Shaona
    LEUKEMIA & LYMPHOMA, 2014, 55 (09) : 2024 - 2031
  • [30] Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib Therapy
    Beyar-Katz, Ofrat
    Magidey, Ksenia
    Reiner-Benaim, Anat
    Barak, Noga
    Avivi, Irit
    Cohen, Yael
    Timaner, Michael
    Avraham, Shimrit
    Hayun, Michal
    Lavi, Noa
    Bersudsky, Marina
    Voronov, Elena
    Apte, Ron N.
    Shaked, Yuval
    MOLECULAR CANCER RESEARCH, 2019, 17 (11) : 2331 - 2340
12345